Comera Life Sciences Performance
| CMRAWDelisted Stock | USD 0.04 0 5.07% |
The firm shows a Beta (market volatility) of 6.15, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Comera Life will likely underperform. Comera Life Sciences right now shows a risk of 0.0%. Please confirm Comera Life Sciences sortino ratio and the relationship between the downside variance and market facilitation index , to decide if Comera Life Sciences will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Comera Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Comera Life is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 2.7 M |
Comera |
Comera Life Relative Risk vs. Return Landscape
If you would invest 3.56 in Comera Life Sciences on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Comera Life Sciences or generate 0.0% return on investment over 90 days. Comera Life Sciences is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Comera, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Comera Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Comera Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Comera Life Sciences, and traders can use it to determine the average amount a Comera Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CMRAW |
Based on monthly moving average Comera Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Comera Life by adding Comera Life to a well-diversified portfolio.
Comera Life Fundamentals Growth
Comera Stock prices reflect investors' perceptions of the future prospects and financial health of Comera Life, and Comera Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Comera Stock performance.
| Return On Equity | -16.29 | |||
| Return On Asset | -1.19 | |||
| Operating Margin | (15.82) % | |||
| Revenue | 1 M | |||
| EBITDA | (7.55 M) | |||
| Cash And Equivalents | 3.86 M | |||
| Cash Per Share | 2.85 X | |||
| Total Debt | 775.05 K | |||
| Debt To Equity | 0.08 % | |||
| Book Value Per Share | (12.62) X | |||
| Cash Flow From Operations | (6.66 M) | |||
| Earnings Per Share | (6.08) X | |||
| Total Asset | 3.73 M | |||
| Retained Earnings | (34.9 M) | |||
About Comera Life Performance
Evaluating Comera Life's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Comera Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Comera Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts. Comera Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.Things to note about Comera Life Sciences performance evaluation
Checking the ongoing alerts about Comera Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Comera Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Comera Life Sciences is not yet fully synchronised with the market data | |
| Comera Life Sciences has some characteristics of a very speculative penny stock | |
| Comera Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1 M. Net Loss for the year was (9.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Comera Life Sciences has accumulated about 3.86 M in cash with (6.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Comera Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Comera Life's stock is overvalued or undervalued compared to its peers.
- Examining Comera Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Comera Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Comera Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Comera Life's stock. These opinions can provide insight into Comera Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Comera Stock
If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |